Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

292 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Paraoxonase-1 and clopidogrel efficacy.
Cuisset T, Morange PE, Quilici J, Bonnet JL, Gachet C, Alessi MC. Cuisset T, et al. Among authors: morange pe. Nat Med. 2011 Sep 7;17(9):1039; author reply 1042-4. doi: 10.1038/nm.2367. Nat Med. 2011. PMID: 21900913 No abstract available.
Usefulness of high clopidogrel maintenance dose according to CYP2C19 genotypes in clopidogrel low responders undergoing coronary stenting for non ST elevation acute coronary syndrome.
Cuisset T, Quilici J, Cohen W, Fourcade L, Saut N, Pankert M, Gaborit B, Carrieri P, Morange PE, Bonnet JL, Alessi MC. Cuisset T, et al. Among authors: morange pe. Am J Cardiol. 2011 Sep 15;108(6):760-5. doi: 10.1016/j.amjcard.2011.05.045. Epub 2011 Jul 30. Am J Cardiol. 2011. PMID: 21803320
Comparison of platelet reactivity and clopidogrel response in patients ≤ 75 Years Versus > 75 years undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndrome.
Cuisset T, Quilici J, Grosdidier C, Fourcade L, Gaborit B, Pankert M, Molines L, Morange PE, Bonnet JL, Alessi MC. Cuisset T, et al. Among authors: morange pe. Am J Cardiol. 2011 Nov 15;108(10):1411-6. doi: 10.1016/j.amjcard.2011.06.060. Epub 2011 Aug 25. Am J Cardiol. 2011. PMID: 21872198
High residual platelet reactivity and thrombotic events.
Cuisset T, Morange PE, Alessi MC. Cuisset T, et al. Among authors: morange pe. JAMA. 2011 Dec 21;306(23):2561; author reply 2561-2. doi: 10.1001/jama.2011.1838. JAMA. 2011. PMID: 22187272 No abstract available.
Recent advances in the pharmacogenetics of clopidogrel.
Cuisset T, Morange PE, Alessi MC. Cuisset T, et al. Among authors: morange pe. Hum Genet. 2012 May;131(5):653-64. doi: 10.1007/s00439-011-1130-6. Epub 2011 Dec 30. Hum Genet. 2012. PMID: 22207144 Review.
Benefit of a 600-mg loading dose of clopidogrel on platelet reactivity and clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing coronary stenting.
Cuisset T, Frere C, Quilici J, Morange PE, Nait-Saidi L, Carvajal J, Lehmann A, Lambert M, Bonnet JL, Alessi MC. Cuisset T, et al. Among authors: morange pe. J Am Coll Cardiol. 2006 Oct 3;48(7):1339-45. doi: 10.1016/j.jacc.2006.06.049. Epub 2006 Sep 12. J Am Coll Cardiol. 2006. PMID: 17010792 Free article. Clinical Trial.
292 results